MEASUREMENT OF SERUM ANTIBODY TITER AGAINST MEASLES IN A GROUP OF ADULTS RECEIVING MEASLES-RUBELLA MASS VACCINATION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

EMAMI NAEINI ALIREZA; GHAZAVI NEGAR; EMAMI NAEINI SAHAR

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S) Year:2011 | Volume:28 | Issue:114 Page(s): 854-858

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

2,719

Download:

Cites:

Information Journal Paper

Title

MEASUREMENT OF SERUM ANTIBODY TITER AGAINST MEASLES IN A GROUP OF ADULTS RECEIVING MEASLES-RUBELLA MASS VACCINATION

Author(s)

EMAMI NAEINI ALIREZA | GHAZAVI NEGAR | EMAMI NAEINI SAHAR | Issue Writer Certificate

Keywords

MEASLESQ2

ANTIBODY TITERQ3

RUBELLAQ3

Abstract

Background: MEASLES vaccination in Iran is an expanded program. Since 1973- 2002, all infants have received live attenuated MEASLES vaccine (0.5 ml, subcutaneous, A.I.K strain) at the 9th and 15th months of life. Before 2002, we confronted outbreaks of MEASLES in previously vaccinated adults from all over the country. Reports showed convincing evidence of secondary MEASLES vaccine failure. The Ministry of Health and Medical Sciences of the Islamic Republic of Iran launched a mass MEASLES-Rubella (MR) vaccination campaign throughout the country from 5 to 31 December 2003. More than 32 million inhabitants between 5 and 25 years old received the MEASLES-Rubella (MR) vaccine. The aim of this program was to eliminate MEASLES and to control congenital RUBELLA syndrome. This study was conducted to determine the prevalence of positive MEASLES ANTIBODY TITERs in a group of adults who received mass MR vaccine.Methods: We conducted this cross-sectional survey on a group of adults 20–30 years old (30 men and 30 women) referred to marriage consulting clinic in Isfahan University of Medical Sciences in 2008. All participants had received routine vaccination against MEASLES during their infancy and MR mass vaccination in December 2003. Serum IgG MEASLES antibody was measured using ELISA (Trinity Biotech, Bay, Ireland). We considered immune serum Ratio (ISR), ANTIBODY TITERs of £ 0.09 IU/ml as negative, 0.91–1.09 IU/ml as intermediate, and ³ 1.10 IU/ml as positive respectively. Data were analyzed by SSPS software Student-t and Pearson correlation tests at the significance level of P<0.05.Finding: In women group, all had positive titers (100%); in men group, 27 (90%) positive titer, two (6.6%) borderlines, and one (3.4) negative titer were seen. The mean serum ANTIBODY TITER in women was 2.02±0.56 IU/ml and in men was 1.91±0.53 IU/ml. The mean serum titer in 20-23 years old group was 1.84 IU/ml, in 24-27 years old was 2.12 IU/ml and in 28-30 years old was 2.17 IU/ml. No statistically significant correlation was found between serum ANTIBODY TITER and age (P=0.136). The correlation between ANTIBODY TITER and sex also did not turn to be statistically significant (P=0.447).Conclusion: In our study, 100% of women and about 96% of men had positive protective serum titer, meaning that there has been a good vaccine induced protection for the majority of vaccinates volunteers. However, for interruption of virus transmission in the community, more than 95% of the population must be protected.

Cites

No record.

References

No record.

Cite

APA: Copy

EMAMI NAEINI, ALIREZA, GHAZAVI, NEGAR, & EMAMI NAEINI, SAHAR. (2011). MEASUREMENT OF SERUM ANTIBODY TITER AGAINST MEASLES IN A GROUP OF ADULTS RECEIVING MEASLES-RUBELLA MASS VACCINATION. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 28(114), 854-858. SID. https://sid.ir/paper/51062/en

Vancouver: Copy

EMAMI NAEINI ALIREZA, GHAZAVI NEGAR, EMAMI NAEINI SAHAR. MEASUREMENT OF SERUM ANTIBODY TITER AGAINST MEASLES IN A GROUP OF ADULTS RECEIVING MEASLES-RUBELLA MASS VACCINATION. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2011;28(114):854-858. Available from: https://sid.ir/paper/51062/en

IEEE: Copy

ALIREZA EMAMI NAEINI, NEGAR GHAZAVI, and SAHAR EMAMI NAEINI, “MEASUREMENT OF SERUM ANTIBODY TITER AGAINST MEASLES IN A GROUP OF ADULTS RECEIVING MEASLES-RUBELLA MASS VACCINATION,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 28, no. 114, pp. 854–858, 2011, [Online]. Available: https://sid.ir/paper/51062/en

Related Journal Papers